Peptide-based Tolerance
Peptide-Based Tolerance is a therapeutic strategy within immune tolerance induction that employs specific antigenic peptides to selectively modulate T-cell responses, thereby promoting immune unresponsiveness to particular self- or foreign antigens while preserving overall immune competence.
61
Publications
5K
Citations
391
Authors
161
Institutions
Publications per year
2017–2026
4
Parents
61
1–5 of 61
391
5
h-index
4
h-index
4
h-index
3
h-index
3
h-index
1–5 of 391
161
University of California, Los Angeles
Los Angeles, United States
5 h-index
25 publications
2K citations
Northwestern University
Evanston, United States
4 h-index
17 publications
4.4K citations

Leiden University Medical Center
Leiden, The Netherlands
3 h-index
13 publications
2.9K citations
Inserm
Paris, France
3 h-index
5 publications
1.3K citations

University of Bristol
Bristol, United Kingdom
3 h-index
13 publications
1.7K citations
Columbia University
New York, United States
3 h-index
17 publications
644 citations
Institute of Neuroimmunology of the Slovak Academy of Sciences
Bratislava, Slovakia
2 h-index
15 publications
2.9K citations
La Jolla Institute for Immunology
San Diego, United States
2 h-index
2 publications
479 citations
1–8 of 161
JI · 20 publications · 1.3K citations
17
h-index
4 publications · 145 citations
4
h-index
EJI · 4 publications · 147 citations
4
h-index
PNAS · 3 publications · 171 citations
3
h-index
2 publications · 255 citations
2
h-index
1–5